Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy.
The interruption of leprosy transmission is one of the main challenges for leprosy control programs since no consistent evidence exists that transmission has been reduced after the introduction of multidrug therapy. Sources of infection are primarily people with high loads of bacteria with or without clinical signs of leprosy. The availability of a simple test system for the detection of antibodies to phenolic glycolipid-I (PGL-I) of Mycobacterium leprae to identify these individuals may be important in the prevention of transmission. We have developed a lateral flow assay, the ML Flow test, for the detection of antibodies to PGL-I which takes only 10 min to perform. An agreement of 91% was observed between enzyme-linked immunosorbent assay and our test; the agreement beyond chance (kappa value) was 0.77. We evaluated the use of whole blood by comparing 539 blood and serum samples from an area of high endemicity. The observed agreement was 85.9% (kappa = 0.70). Storage of the lateral flow test and the running buffer at 28 degrees C for up to 1 year did not influence the results of the assay. The sensitivity of the ML Flow test in correctly classifying MB patients was 97.4%. The specificity of the ML Flow test, based on the results of the control group, was 90.2%. The ML Flow test is a fast and easy-to-perform method for the detection of immunoglobulin M antibodies to PGL-I of M. leprae. It does not require any special equipment, and the highly stable reagents make the test robust and suitable for use in tropical countries.
Bührer-Sékula
S
S
KIT (Royal Tropical Institute) Biomedical Research, 1105 AZ Amsterdam, The Netherlands. s.buhrer@kit.nl
Smits
H L
HL
Gussenhoven
G C
GC
van Leeuwen
J
J
Amador
S
S
Fujiwara
T
T
Klatser
P R
PR
Oskam
L
L
D000907:Antibodies, Bacterial / Q000097:blood*; D000942:Antigens, Bacterial / Q000737:chemistry; D002240:Carbohydrate Sequence; D016022:Case-Control Studies; D004797:Enzyme-Linked Immunosorbent Assay; D006017:Glycolipids / Q000737:chemistry / Q000276:immunology; D006801:Humans; D007118:Immunoassay / Q000379:methods* / Q000706:statistics & numerical data; D007075:Immunoglobulin M / Q000097:blood; D007918:Leprosy / Q000145:classification* / Q000276:immunology* / Q000517:prevention & control / Q000635:transmission; D008969:Molecular Sequence Data; D009166:Mycobacterium leprae / Q000276:immunology*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D006017:Glycolipids; D007075:Immunoglobulin M; C045169:phenolic glycolipid I, Mycobacterium leprae